Advertisement

Journal of Inherited Metabolic Disease

, Volume 41, Issue 6, pp 913–914 | Cite as

Letter to the Editors: Concerning “Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia” by Lee et al.

  • Elizabeth D. Brooks
  • Priya S. Kishnani
  • Dwight D. KoeberlEmail author
Letter to the Editors
  • 340 Downloads

Notes

Compliance with ethical standards

Conflict of interest

Elizabeth D. Brooks, Priya Kishnani, and Dwight D. Koeberl have no conflicts of interest to report.

References

  1. Brooks ED, Landau DJ, Everitt JI et al (2018) Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. J Inherit Metab Dis.  https://doi.org/10.1007/s10545-018-0223-y Google Scholar
  2. Lee YM, Conlon TJ, Specht A et al (2018) Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia. J Inherit Metab Dis.  https://doi.org/10.1007/s10545-018-0199-7 Google Scholar

Copyright information

© SSIEM 2018

Authors and Affiliations

  1. 1.Division of Medical GeneticsDuke University Medical CenterDurhamUSA
  2. 2.Division of Laboratory Animal ResourcesDuke University Medical CenterDurhamUSA

Personalised recommendations